- April 15, 2016
Best Practices – ADA & Joint Commission Guidelines
In our previous blog, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include: hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and Hospital Acquired Conditions (HACs).
- Insulin – the preferred method of glycemic control in the hospital setting.
- Sliding Scale Insulin (SSI) – the method referring to progressive increase in pre-meal or nighttime insulin dose based on pre-defined blood glucose ranges. This method is strongly discouraged in the hospital setting as the sole method of treatment.
- Glucose Range – once insulin therapy begins, a target glucose range of 140-180 mg/dL (7.8-10.0 mmol/L) is recommended for most critically ill and noncritically ill patients.
- Stringent Targets – the target range of 110-140 mg/dL is appropriate for selected critically ill patients without increasing the risk of hypoglycemia.
In our next blog, we will uncover the facts behind the positive outcomes of inpatient glucose control.
Be on the lookout for more of the Inpatient Glucose Management Infographic, or, download the Inpatient Glucose Management Infographic today to view it all!